JP2024511881A5 - - Google Patents
Info
- Publication number
- JP2024511881A5 JP2024511881A5 JP2023560997A JP2023560997A JP2024511881A5 JP 2024511881 A5 JP2024511881 A5 JP 2024511881A5 JP 2023560997 A JP2023560997 A JP 2023560997A JP 2023560997 A JP2023560997 A JP 2023560997A JP 2024511881 A5 JP2024511881 A5 JP 2024511881A5
- Authority
- JP
- Japan
- Prior art keywords
- dimethyl
- cyclopropyl
- azabicyclo
- carboxamide
- hexane
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB2104742.8 | 2021-04-01 | ||
| GBGB2104742.8A GB202104742D0 (en) | 2021-04-01 | 2021-04-01 | Sars-Cov-2 MPRO inhibitor compounds |
| GB2107026.3 | 2021-05-17 | ||
| GBGB2107026.3A GB202107026D0 (en) | 2021-05-17 | 2021-05-17 | SARS-COV-2 MPRO inhibitor compounds |
| PCT/GB2022/050836 WO2022208113A1 (en) | 2021-04-01 | 2022-04-01 | Sars-cov-2 mpro inhibitor compounds |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024511881A JP2024511881A (ja) | 2024-03-15 |
| JP2024511881A5 true JP2024511881A5 (cg-RX-API-DMAC7.html) | 2025-04-09 |
Family
ID=81307814
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023560997A Pending JP2024511881A (ja) | 2021-04-01 | 2022-04-01 | SARS-COV-2 Mpro阻害剤化合物 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20240217930A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4313305A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2024511881A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20240004275A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2022247287A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3213008A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2022208113A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2023283256A1 (en) | 2021-07-09 | 2023-01-12 | Aligos Therapeutics, Inc. | Anti-viral compounds |
| US12065428B2 (en) | 2021-09-17 | 2024-08-20 | Aligos Therapeutics, Inc. | Anti-viral compounds |
| AU2023303408A1 (en) | 2022-07-06 | 2024-12-19 | Aligos Therapeutics, Inc. | Anti-viral compounds |
| GB202214644D0 (en) * | 2022-10-05 | 2022-11-16 | Heptares Therapeutics Ltd | Sars-cov-2 mpro inhibitors and uses thereof |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7244721B2 (en) * | 2000-07-21 | 2007-07-17 | Schering Corporation | Peptides as NS3-serine protease inhibitors of hepatitis C virus |
| US7012066B2 (en) * | 2000-07-21 | 2006-03-14 | Schering Corporation | Peptides as NS3-serine protease inhibitors of hepatitis C virus |
| CA3180177A1 (en) * | 2020-05-08 | 2021-11-11 | The Board Of Trustees Of The Leland Stanford Junior University | Protease inhibitors for treatment or prevention of coronavirus disease |
-
2022
- 2022-04-01 CA CA3213008A patent/CA3213008A1/en active Pending
- 2022-04-01 KR KR1020237033735A patent/KR20240004275A/ko active Pending
- 2022-04-01 EP EP22716453.0A patent/EP4313305A1/en active Pending
- 2022-04-01 US US18/553,596 patent/US20240217930A1/en active Pending
- 2022-04-01 JP JP2023560997A patent/JP2024511881A/ja active Pending
- 2022-04-01 WO PCT/GB2022/050836 patent/WO2022208113A1/en not_active Ceased
- 2022-04-01 AU AU2022247287A patent/AU2022247287A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2494095C2 (ru) | Модифицированные миметики лизина | |
| CN105283177B (zh) | 用作组蛋白脱甲基酶kdm1a的抑制剂的环丙胺衍生物 | |
| JP2023529354A5 (cg-RX-API-DMAC7.html) | ||
| RU2471781C2 (ru) | Новые двузамещенные фенилпирролидины в качестве модуляторов кортикальной катехоламинергической нейротрансмиссии | |
| TW202327569A (zh) | 包含tead抑制劑的藥物組合及其用於癌症治療之用途 | |
| CN105121430B (zh) | 用于治疗自身免疫性和炎性疾病的类维生素A相关的孤儿受体γ(RORγ)的调节剂 | |
| CN104395288B (zh) | 用于治疗尤文肉瘤家族肿瘤的方法和组合物 | |
| RU2018127315A (ru) | Индуцирующие апоптоз средства для лечения злокачественной опухоли и иммунологических и аутоиммунных заболеваний | |
| SI9420017A (en) | Hiv protease inhibitors in pharmaceutical combinations for the treatment of aids | |
| JP2018507877A5 (cg-RX-API-DMAC7.html) | ||
| EA001221B1 (ru) | Тгф-содержащие сульфонамидные ингибиторы аспартил-протеазы | |
| JP6217866B2 (ja) | Kcnq2〜5チャネル活性化剤 | |
| JP2007538024A5 (cg-RX-API-DMAC7.html) | ||
| JP2021513972A (ja) | 社会的機能障害の治療方法 | |
| JP2024545135A5 (cg-RX-API-DMAC7.html) | ||
| CN1082543A (zh) | 吲哚衍生物 | |
| JP2012509940A5 (cg-RX-API-DMAC7.html) | ||
| JP2024508045A5 (cg-RX-API-DMAC7.html) | ||
| JP2023545046A5 (cg-RX-API-DMAC7.html) | ||
| JPWO2009136625A1 (ja) | 環状アミン−1−カルボン酸エステル誘導体およびそれを含有する医薬組成物 | |
| JP2019516707A5 (cg-RX-API-DMAC7.html) | ||
| JP2023547241A5 (cg-RX-API-DMAC7.html) | ||
| JP2016512232A (ja) | 運動障害の予防又は治療用フェニルカルバメート化合物 | |
| JP2023525359A5 (cg-RX-API-DMAC7.html) | ||
| IL293703A (en) | Lysine-specific histone demethylase inhibitors for the treatment of myeloproliferative neoplasms |